Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
10.9%
% of IBB's 214 holdings also in HRTS
53.8%
% of HRTS's 39 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 8.2% | 5.7% | 5.7% |
|
AMGEN INC | 7.5% | 5.1% | 5.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.1% | 4.7% | 3.1% |
|
REGENERON PHARMACEUTICALS | 5.6% | 2.4% | 2.4% |
|
ASCENDIS PHARMA A/S | 0.6% | 3.1% | 0.6% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to HRTS
|
GILEAD SCIENCES INC | 9.8% |
|
IQVIA HOLDINGS INC | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.2% |
 |
ARGENX SE ADR | 3.0% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
BIOGEN IDEC INC | 2.4% |
|
AMGEN INC | 2.3% |
|
ILLUMINA INC | 2.2% |
|
WATERS CORP | 2.2% |
IBB Underweight Relative to HRTS
|
ELI LILLY & CO | -6.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
 |
NOVO NORDISK A/S-B | -3.6% |
|
BRIDGEBIO PHARMA, INC. | -3.4% |
|
CRINETICS PHARMACEUTICALS INC | -3.4% |
 |
ASTRAZENECA PLC | -3.1% |
|
BOSTON SCIENTIFIC CORP | -3.1% |
 |
MEDTRONIC PLC | -3.0% |
|
DEXCOM INC | -2.7% |
|
CYTOKINETICS INC | -2.7% |